Lifecore Biomedical, Inc. (LFCR) To Be Acquired for $6.28/Share Cash Plus CVR

Lifecore agreed to be acquired by Webster Equity Partners for $6.28 per share in cash plus a non-tradable CVR worth up to $160M, subject to milestones. Closing is expected by end of Q4 2026, pending approvals.Material DetailsContext by AI AnalystThis is a late-stage development culminating in a cha…